Targacept, Inc. is a biopharmaceutical company developing a diverse pipeline of NNR TherapeuticsTM. NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.
Current Team (2)Update
Board Members and Advisors (4)Update
200 East First Street
Winston Salem, NC 27101-4165